Opioid Mortality on the Rise in US Children

Slideshow

Most data on US opioid-related deaths come from adults, but a recent study shows pediatric opioid deaths are on the rise at an alarming rate.

Recent Videos
Related Content
American College of Gastroenterology Releases Updated Guidelines for Eosinophilic Esophagitis / Image credit: ©Naeblys/AdobeStock

American College of Gastroenterology Releases Updated Guidelines for Eosinophilic Esophagitis

Sydney Jennings
January 7th 2025
Article

The updated guidelines include 19 recommendations related to the diagnosis and management of eosinophilic esophagitis.

Prenatal Antibiotic Exposure Linked to Childhood Health Issues: Daily Dose / image credit: ©New Africa/AdobeStock

Prenatal Antibiotic Exposure Linked to Childhood Health Issues: Daily Dose

Sydney Jennings
January 7th 2025
Article

Your daily dose of the clinical news you may have missed.

Fremanezumab for Prevention of Episodic Migraine in Children: Daily Dose / image credit: ©New Africa/AdobeStock

Fremanezumab for Prevention of Episodic Migraine in Children: Daily Dose

Sydney Jennings
December 19th 2024
Article

Your daily dose of the clinical news you may have missed.

Prenatal Exposure to Antibiotics May increase risk for Long-Term Health Risks in Children JenkoAtaman/stock.adobe.com

Prenatal Exposure to Antibiotics May Increase Risk for Long-Term Health Problems in Children

Sofia Abene
December 18th 2024
Article

The potential adverse outcomes include asthma, food allergies, cerebral palsy, and cancer, according to a recent systematic review and meta-analysis.

FDA Accepts Merck's BLA for Clesrovimab, an Investigational mAb Against RSV in Infants

FDA Accepts Merck's BLA for Clesrovimab, an Investigational mAb Against RSV in Infants

Grace Halsey
December 17th 2024
Article

Clesrovimab, if approved, would be the only immunization for both healthy and at risk infants using the same dose. FDA set A PDUFA date of June 2025.

Safety of Moderna’s mRNA RSV Vaccine for Infants Heads Dec 12 VRBPAC Meeting Agenda / image credit Naumov_2/stock.adobe.com

Safety of Moderna’s mRNA RSV Vaccine for Infants Heads Dec 12 VRBPAC Meeting Agenda

Grace Halsey
December 11th 2024
Article

Moderna paused clinical research on the pediatric shot indefinitely in September after reports in July of severe adverse reactions in infants aged 5 to 8 months.

© 2025 MJH Life Sciences

All rights reserved.